EUVIMEDEUVIMED entdecken
Crossref

The Application of DNA Ploidy Analysis in Large-Scale Population Screening for Cervical Cancer

Yulin Guo, Qiuzi Peng, Ying Wang, Lu Li, Xiaoyun Yi, Bin Yan, Miao Zou, Guohong Dai, Peng Guo, Quanfu Ma, Xufeng Wu

Acta Cytologica · 2021 · 65 (5) · 385-392

DOI: 10.1159/000518052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Cytologica, online erschienen am 20.08.2021. Verfasst von Yulin Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, China. Hauptthemen laut MEDLINE: Mass Screening. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study was to evaluate the application of DNA ploidy analysis in large-scale population screening for cervical cancer.

Methods

From March 2016 to March 2019, eligible subjects were enrolled and recommended to undergo DNA ploidy analysis, the ThinPrep cytology test (TCT), and high-risk human papillomavirus (hrHPV) detection concurrently. Patients with positive results were recommended for colposcopy, and biopsy diagnosis was regarded as the “gold standard.” We compared the test efficiencies of the 3 methods and compared the efficiency and accuracy of the TCT in our hospital and the “2-cancer screening” project in Hubei Province during the same period.

Results

Among 20,574 women, the positive rates of DNA ploidy analysis, cytology, and hrHPV testing were 4.01%, 4.71%, and 16.28%, respectively. The sensitivities of these methods for screening for grade 2+ cervical intraepithelial neoplasia were 0.70, 0.68, and 0.96, and their specificities were 0.79, 0.82, and 0.45, respectively. On comparing DNA ploidy analysis with the TCT, there was no significant difference in the sensitivity, specificity, positive predictive value, negative predictive value, and missed diagnosis rate. In opportunistic screening and the 2-cancer screening project, the positive rates of cytology were 4.71% and 2.87%, respectively. And the efficiency and accuracy of the TCT in opportunistic screening were higher than in the 2-cancer screening project.

Conclusion

Therefore, DNA ploidy analysis, which is of low-cost and does not depend on cytopathologists, can replace cytology and be applied in large-scale population screening for cervical cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mass ScreeningAdultBiopsyCytodiagnosisDNAEarly Detection of CancerFemaleHumansMiddle AgedPapillomaviridaePapillomavirus InfectionsPregnancySensitivity and SpecificityUterine Cervical NeoplasmsYoung AdultUterine Cervical Dysplasia

Stichwörter der Autor:innen

Cervical cancerDNA ploidy analysisPopulation screening

Substanzen

DNA

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, China.
  • Cervical Cancer Control Center of Hubei Province, Wuhan, China.

Zitieren

APA

Guo, Y., Peng, Q., Wang, Y., Li, L., Yi, X., Yan, B., Zou, M., Dai, G., Guo, P., Ma, Q., & Wu, X. (2021). The Application of DNA Ploidy Analysis in Large-Scale Population Screening for Cervical Cancer. Acta Cytologica, 65(5), 385-392. https://doi.org/10.1159/000518052

Vancouver

Guo Y, Peng Q, Wang Y, Li L, Yi X, Yan B, et al. The Application of DNA Ploidy Analysis in Large-Scale Population Screening for Cervical Cancer. Acta Cytologica. 2021;65(5):385-392. doi:10.1159/000518052

BibTeX
@article{Guo2021,
  author = {Guo, Yulin and Peng, Qiuzi and Wang, Ying and Li, Lu and Yi, Xiaoyun and Yan, Bin and Zou, Miao and Dai, Guohong and Guo, Peng and Ma, Quanfu and Wu, Xufeng},
  title = {The Application of DNA Ploidy Analysis in Large-Scale Population Screening for Cervical Cancer},
  journal = {Acta Cytologica},
  year = {2021},
  volume = {65},
  number = {5},
  pages = {385--392},
  doi = {10.1159/000518052}
}
Kostenlos starten →